Zeuzem, S; Arora, S; Bacon, B et al.
PEGYLATED INTERFERON-LAMBDA (PEGIFN-lambda) SHOWS SUPERIOR VIRAL RESPONSE WITH IMPROVED SAFETY AND TOLERABILITY VERSUS PEGIFN alpha-2A IN HCV PATIENTS (G1/2/3/4): EMERGE PHASE IIB THROUGH WEEK 12JOURNAL OF HEPATOLOGY. Bd. 54. 2011 S. S538-S539
Huang, YW; Sprinzl, M
Peptide Bond Formation on the Ribosome: The Role of the 2 '-OH Group on the Terminal Adenosine of Peptidyl-tRNA and of the Length of Nascent Peptide ChainANGEWANDTE CHEMIE-INTERNATIONAL EDITION. Bd. 50. H. 32. 2011 S. 7287-7289
Rossol, S; Schuchmann, M; Mauss, S et al.
PHARMAECONOMIC EVALUATION OF CHRONIC HCV TREATMENT WITH PEGINTERFERON ALFA-2A/RIBAVIRN - REAL LIFE SETTING IN A LARGE GERMAN COHORT OF 1147 PATIENTSHEPATOLOGY. Bd. 54. 2011 S. 858A-859A
Kim, HS; Kim, JY; Ryu, HS et al.
Phenotypic and Functional Maturation of Dendritic Cells Induced by Polysaccharide Isolated from Paecilomyces cicadaeJOURNAL OF MEDICINAL FOOD. Bd. 14. H. 7-8. 2011 S. 847-856
Maurer, A; Schwarting, A; Kahaly, GJ
Polyglandular autoimmune syndromesZEITSCHRIFT FUR RHEUMATOLOGIE. Bd. 70. H. 9. 2011 S. 752-+
Hartmann, C; Schuchmann, M; Zimmermann, T
Posttransplant lymphoproliferative disease in liver transplantationCurr Infect Dis Rep. Bd. 13. H. 1. 2011 S. 53-9
Manns, MP; Bourliere, M; Benhamou, Y et al.
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infectionJOURNAL OF HEPATOLOGY. Bd. 54. H. 6. 2011 S. 1114-1122
Mauss, S; Schober, A; Lutz, T et al.
Predictive Factors of Thrombocytopenia in Treatment of Chronic Hepatitis C (CHC) Patients With Peginterferon Alfa-2a (40KD) and RibavirinGASTROENTEROLOGY. Bd. 140. H. 5. 2011 S. S948-S948
Mauss, S; Schober, A; Lutz, T et al.
PREDICTIVE FACTORS OF THROMBOCYTOPENIA IN TREATMENT OF CHRONIC HEPATITIS C (CHC) PATIENTS WITH PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRINJOURNAL OF HEPATOLOGY. Bd. 54. 2011 S. S185-S185
Mayet, WJ
Preface to AGG-publications in the Journal of GastroenterologyZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 49. H. 4. 2011 S. 429-429